News
![GrafTech Announces Fourth Quarter 2022 Cash Dividend: https://mms.businesswire.com/media/20191107005161/en/655890/5/GrafTech%2520International%2520%28Color%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNWNqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--040fe8bb6c5e9575e9f8179335476cf49b802944/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GrafTech-2520International-2520-28Color-29.jpg?locale=us)
GrafTech Announces Fourth Quarter 2022 Cash Dividend
The Board of Directors of GrafTech International Ltd. (NYSE:EAF) (the “Company”) declared a quarterly cash dividend of $0.01 per share to stockholders of record as of the close of business on
![Archaea Energy Inc. Reports Results for the Three and Nine Months Ended September 30, 2022: https://mms.businesswire.com/media/20220630005677/en/1502420/5/Archaea_1400px.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN2kyV0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e83af2efd7bce08281b8af99a239becf3cb4d41b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Archaea_1400px.jpg?locale=us)
Archaea Energy Inc. Reports Results for the Three and Nine Months Ended September 30, 2022
Archaea Energy Inc. (“Archaea,” “the Company,” or “we”) (NYSE: LFG), one of the largest producers of renewable natural gas (“RNG”) in the U.S., today announced financial and operating results for
![Vistagen Reports Second Quarter Financial Results and Provides Corporate Update: https://mms.businesswire.com/media/20220908005443/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeTRUV1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--73b36512c2c3a38ef5ed55a7e6cdd41ef91198d5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Vistagen_Primary-Logo_Blue.jpg?locale=us)
Vistagen Reports Second Quarter Financial Results and Provides Corporate Update
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system
![US Foods to Present at the 2022 Barclays Eat, Sleep, Play Conference: https://mms.businesswire.com/media/20191107005203/en/650770/5/USF_LOGOWITHOUTTAG_RGB_WEB.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEVqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b3a951f3d3733dc9ca6392c07ce1ec04f2a28e35/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/USF_LOGOWITHOUTTAG_RGB_WEB.jpg?locale=us)
US Foods to Present at the 2022 Barclays Eat, Sleep, Play Conference
US Foods Holding Corp. (NYSE: USFD) announced today that Dirk Locascio, chief financial officer, will participate in a fireside chat at the Barclays Eat, Sleep, Play Conference in New York City on
![Stevanato Group to Present at Upcoming Investor Conference: https://mms.businesswire.com/media/20220601006234/en/1474001/5/JPG_Logo_SG_RGB.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2lTV0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b2f041e985c928ae88be33159fcbf865323db61c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/JPG_Logo_SG_RGB.jpg?locale=us)
Stevanato Group to Present at Upcoming Investor Conference
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries
![COPT Declares 100th Consecutive Common Dividend: https://mms.businesswire.com/media/20191107006031/en/58018/5/COPT_2ColorRGB.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNFlsRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d7fd313873062f6bf3c7c9c36361eaf642a53358/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/COPT_2ColorRGB.jpg?locale=us)
COPT Declares 100th Consecutive Common Dividend
Corporate Office Properties Trust (NYSE: OFC) (“COPT” or the “Company”) announced today that its Board of Trustees declared a regular quarterly dividend of $0.275 per common share for the fourth
![Savara Reports Third Quarter 2022 Financial Results and Provides Business Update: https://mms.businesswire.com/media/20200730005071/en/747459/5/SavaraLogo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXNWUlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--30282242e6a53f7234dfd6a72990cb1138b07d13/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/SavaraLogo.jpg?locale=us)
Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2022 and provided
![Xylem Inc. Declares Fourth Quarter Dividend of 30 Cents per Share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24843/Xylem_Logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBajhEIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--ff9cb640e3d6efcad8a7576b19f3edd05b9706a2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Xylem_Logo.png?locale=us)
Xylem Inc. Declares Fourth Quarter Dividend of 30 Cents per Share
The Board of Directors of Xylem Inc. (NYSE: XYL), has declared a fourth quarter dividend of $0.30 per share payable on December 20, 2022 to shareholders of record as of November 22, 2022.
About
![Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update: https://mms.businesswire.com/media/20191210005404/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDJtRmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--72b88093378d3ac7af38e94191d21fae0c1daae8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LINEAGE_SCREEN_JPEG_1800x360.jpg?locale=us)
Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported financial and
![Eaton achieves Mansfield Rule certification: What this means for the future of inclusion and diversity: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24410/Eaton_Color_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBY1E9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--ea37be97eddf60340bd98929e037c2269632c8e7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Eaton_Color_logo.png?locale=us)
Eaton achieves Mansfield Rule certification: What this means for the future of inclusion and diversity
Intelligent power management company Eaton (NYSE:ETN) is excited to announce that it has been named a Mansfield 2.0 Certified Legal Department (MRLD) and achieved the MRLD Certification Plus
![Xencor to Present at Upcoming Investor Conferences: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNElsRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c4d0ef2109eb59269aca9850381b8fb5000d84e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Xencor_RGB_fullcolor.jpg?locale=us)
Xencor to Present at Upcoming Investor Conferences
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that
![IMV Inc. Announces Third Quarter 2022 Financial and Operational Results: https://mms.businesswire.com/media/20200225005324/en/775456/5/IMV_Logos_IMV-Logo_BrandStatement.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenlNSlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--44b7c2e9ec1d34b6817ce17f4c733565e4a558a7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/IMV_Logos_IMV-Logo_BrandStatement.jpg?locale=us)
IMV Inc. Announces Third Quarter 2022 Financial and Operational Results
IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or the “Company”), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat
![Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended
![Columbia Care Continues Footprint Expansion in Virginia with New Dispensary Opening in Richmond: https://mms.businesswire.com/media/20200203005819/en/720533/5/CC_CORPORATE_-01.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2hVSVE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9aaf56e524d07c92645b5246a555901838c3aad7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/CC_CORPORATE_-01.jpg?locale=us)
Columbia Care Continues Footprint Expansion in Virginia with New Dispensary Opening in Richmond
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis
![AgeX Therapeutics Reports Third Quarter 2022 Financial Results: https://mms.businesswire.com/media/20191108005662/en/711989/5/AGEX_High_Resolution_300dpi.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2s1RUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--00ef9f30c62ad613a4ffc2725532c06aa86f7fef/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AGEX_High_Resolution_300dpi.jpg?locale=us)
AgeX Therapeutics Reports Third Quarter 2022 Financial Results
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter
![Redfin Reports Annual Home Price Growth Slows to 3%: https://mms.businesswire.com/media/20221109005873/en/1407505/5/Redfin_Standard_Web_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnBtV1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b6eecc2a1cb4ad83ef669c09bd1f4a1520d72706/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Redfin_Standard_Web_Logo.jpg?locale=us)
Redfin Reports Annual Home Price Growth Slows to 3%
(NASDAQ: RDFN) — Home-sale prices rose 3.2% year over year during the four-week period ending November 6, the smallest increase since July 2020, according to a new report from Redfin (redfin.com)
![EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue significantly increases to €125.8 million in 9M 2022 with adjusted EBITDA of €47.6 million (37.9% margin); Forecast 2022 raised](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue significantly increases to €125.8 million in 9M 2022 with adjusted EBITDA of €47.6 million (37.9% margin); Forecast 2022 raised
![Emma de Sousa to step down as Insight’s EMEA President; Adrian Gregory to take the helm: https://mms.businesswire.com/media/20191108005290/en/699137/5/Insight_Logo__Med.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM29rRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e6fab02a2aea738283cfec9df328bd6044f772cb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Insight_Logo__Med.jpg?locale=us)
Emma de Sousa to step down as Insight’s EMEA President; Adrian Gregory to take the helm
Insight Enterprises (NASDAQ:NSIT), a Fortune 500 solutions integrator helping organizations accelerate their digital journey, announced today that Emma de Sousa is stepping down from her current
![Teleperformance: Resuming Trading of Shares: https://mms.businesswire.com/media/20191104005672/en/676465/5/logo_-_new.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMmtqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--962a7d9f0913a6de3def41c1b56a4583ad5632a4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo_-_new.jpg?locale=us)
Teleperformance: Resuming Trading of Shares
Regulatory News:
Teleperformance (Paris:TEP), the global leader in outsourced customer and citizen experience management and related digital services, has requested Euronext Paris to resume the
![EQS-News: Cryptology’s estimated NAV per share as of 09/11/2022 is €4.60](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
EQS-News: Cryptology’s estimated NAV per share as of 09/11/2022 is €4.60
![ServiceNow to Present at Upcoming Investor Conferences: https://mms.businesswire.com/media/20200429005875/en/788155/5/ServiceNow_logo_registered_april_28_2020.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlZ1TWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3bb421ae697086e5a71baa9939d78bf25c7a99cf/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ServiceNow_logo_registered_april_28_2020.jpg?locale=us)
ServiceNow to Present at Upcoming Investor Conferences
ServiceNow (NYSE: NOW) today announced that it will attend and have executives present at three upcoming investor conferences. These include:
-
ServiceNow Chairman and Chief Executive Officer Bill
![Fuller, Smith & Turner PLC: Transaction in Own Shares](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Fuller, Smith & Turner PLC: Transaction in Own Shares
![EQS-News: exceet Group SCA: Financial Results Nine Months 2022](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
EQS-News: exceet Group SCA: Financial Results Nine Months 2022
![Employee Engagement is Key in the New Talent Landscape: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBekQ3VlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--749a83316ab9c12370626f8e1fc75f740f454d82/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ISG_-28R-29_Logo.jpg?locale=us)
Employee Engagement is Key in the New Talent Landscape
Enterprises and service providers are facing a talent crunch that requires them to double down on employee engagement programs to attract and retain people with critical skill sets, says an expert
![Custodian REIT plc : Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)